Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.
This review focuses on the laboratory biochemical tests that are useful in the diagnostic approach to the hypertensive patient. A "minimal" diagnostic laboratory work-up, including a small number of tests that are simple and relatively inexpensive, is first described. Because these tests provide basic information on the presence of major cardiovascular (CV) risk factors and target organ damage, and might give some clues to the presence of a secondary form of hypertension (HT), they should be performed on all patients presenting with HT. Other tests that are aimed at assessing the overall CV risk, a major determinant of prognosis that dictates the therapeutic strategy in the individual HT patient, are then discussed. They allow identification of major CV risk factors and associated clinical conditions which, if present, lead to a substantial change of therapeutic strategy. The role of C-reactive protein as a marker of atherosclerosis and its predictive value for CV events are also discussed. Finally, a section is devoted to tests that are currently confined to research purposes, such as markers of endothelial function including endothelin-1, homocysteine and genetic analysis.
Seccia
Teresa M
TM
Department of Clinical Methodology and Medical-Surgical Technologies, University of Bari, Bari, Italy.
Rossi
Gian Paolo
GP
D000818:Animals; D015415:Biomarkers; D003955:Diagnostic Tests, Routine; D006710:Homocysteine / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology*; D007668:Kidney / Q000502:physiology; D012307:Risk Factors
D015415:Biomarkers; D006710:Homocysteine